Unknown

Dataset Information

0

Arterial Hypertension as a Risk Comorbidity Associated with COVID-19 Pathology.


ABSTRACT: Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), is an ongoing global public health challenge. Current clinical data suggest that, in COVID-19 patients, arterial hypertension (AH) is one of the most common cardiovascular comorbidities; it can worsen outcomes and increase the risk of admission to intensive care unit (ICU). The exact mechanisms through which AH contributes to the poor prognosis in COVID-19 are not yet clear. The putative relationship between AH and COVID-19 may be linked to the role of angiotensin-converting enzyme 2 (ACE2), a key element of the AH pathophysiology. Another mechanism connecting AH and COVID-19 is the dysregulation of the immune system resulting in a cytokine storm, mediated by an imbalanced response of T helper cells subtypes. Therefore, it is essential to optimize blood pressure control in hypertensive patients and monitor them carefully for cardiovascular and other complications for the duration of COVID-19 infection. The question whether AH-linked ACE2 gene polymorphisms increase the risk and/or worsen the course of SARS-CoV-2 infection should also receive further consideration.

SUBMITTER: Kamyshnyi A 

PROVIDER: S-EPMC7803108 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

Arterial Hypertension as a Risk Comorbidity Associated with COVID-19 Pathology.

Kamyshnyi Alexander A   Krynytska Inna I   Matskevych Victoriya V   Marushchak Mariya M   Lushchak Oleh O  

International journal of hypertension 20201204


Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), is an ongoing global public health challenge. Current clinical data suggest that, in COVID-19 patients, arterial hypertension (AH) is one of the most common cardiovascular comorbidities; it can worsen outcomes and increase the risk of admission to intensive care unit (ICU). The exact mechanisms through which AH contributes to the poor prognosis in COVID-19 are not ye  ...[more]

Similar Datasets

| S-EPMC7499357 | biostudies-literature
2022-06-16 | GSE178399 | GEO
| S-EPMC7929005 | biostudies-literature
| S-EPMC7229939 | biostudies-literature
| S-EPMC3787920 | biostudies-other
| S-EPMC8112195 | biostudies-literature
| S-EPMC8420356 | biostudies-literature
| S-EPMC2894407 | biostudies-literature
| S-EPMC8576055 | biostudies-literature